Corre C., Lowden P.A.S. (2003) The first biosynthetic studies on the azinomycins. Submitted to Chemical Communications.Lowden P.A.S., Böhm G.A., Metcalfe S., Staunton J. Leadlay P.F. (2003). New rapamycin derivatives by precursor-directed biosynthesis. Accepted for publication in ChemBioChem.Hockly E., Richon V.M., Woodman B., Smith D.L., Zhou X.B., Rosa E., Sathasivam K., Ghazi-Noori S., Mahal A., Lowden P.A.S., Steffan J.S., Marsh J.L., Thompson L.M., Lewis C.M., Marks P.A., Bates G.P. (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proceedings of the National Academy of Sciences of the United States of America 100(4):2041-2046.Smith D.L., Woodman B., Mahal A., Sathasivam K., Ghazi-Noori S., Lowden P.A.S., Bates G.P., Hockly E. (2003) Minocycline and doxycycline are not beneficial in a model of Huntington's disease. Annals of Neurology 54(2):186-196.Giles G.I., Giles N.M., Collins C.A., Holt K., Fry F.H., Lowden P.A.S., Gutowski N.J., Jacob C. (2003). Electrochemical, in vitro and cell culture analysis of integrated redox catalysts: implications for cancer therapy. Chemical Communications (16):2030-2031.
